Lung complications of cancer therapy
Specialist respiratory assessment for lung complications related to cancer therapy, including investigation of symptoms and guidance on appropriate management.
What are lung complications of cancer treatment?
Lung complications of cancer treatment are problems affecting the airways, air sacs or surrounding lung tissue that develop during or after cancer therapy. They can cause breathlessness, cough, fever, chest discomfort or changes on a chest scan, although some are first detected on imaging before they cause obvious symptoms.
Different cancer treatments can affect the lungs in different ways. Radiotherapy can inflame lung tissue within the treatment area; chemotherapy, targeted treatments and immunotherapy can sometimes cause drug-related inflammation; and treatments that suppress the immune system can increase susceptibility to respiratory infection.
One important term is pneumonitis. This means inflammation within the lung tissue and is different from pneumonia, which refers to lung infection. The distinction matters because infection, treatment-related inflammation, cancer progression and other medical problems can produce similar symptoms or appearances on a CT scan but may require very different treatment.
Lung problems may be acute, developing during treatment or over days to weeks; delayed, appearing weeks or months later; or occasionally leave longer-term changes such as pulmonary fibrosis. The timing depends on the treatment, the underlying condition and individual risk factors.
Symptoms of lung complications from cancer treatment
Symptoms vary according to the type and severity of the complication. Any new or worsening respiratory symptom during cancer treatment deserves attention, particularly during chemotherapy or immunotherapy.
Some people have few symptoms despite an abnormal scan, while others can become unwell over a relatively short period.
Breathlessness
New shortness of breath, becoming more breathless on exertion or a noticeable deterioration in an existing breathing problem.
Persistent or new cough
A dry cough is common with pneumonitis, although infection and other causes may produce cough with sputum.
Fever or feeling unwell
Fever, chills or a general deterioration may indicate infection, but fever can also accompany inflammatory lung complications.
Chest discomfort
Chest tightness or pain has many possible causes during cancer treatment and should not simply be assumed to come from the lungs.
Reduced exercise tolerance
Walking, climbing stairs or everyday activities may become noticeably harder because of impaired breathing or oxygen exchange.
Unexpected scan changes
Pneumonitis or other lung abnormalities may sometimes be identified on CT imaging before significant respiratory symptoms develop.
When should I seek medical help?
New respiratory symptoms during or after cancer treatment should be taken seriously because treatment-related inflammation, infection and other complications can initially look very similar.
New or worsening symptoms
Contact your treating oncology team using the advice or emergency number they have given you if you develop a new persistent cough, breathlessness, wheeze, fever or worsening of a pre-existing breathing problem.
This is particularly important while receiving chemotherapy or immunotherapy and can remain important after treatment has finished.
Persistent or unexplained problems
Respiratory review can be particularly useful when symptoms or scans remain unexplained, when infection and treatment toxicity are difficult to distinguish, or when an opinion is needed on the extent of lung involvement.
A private respiratory consultation should complement, rather than replace, communication with your oncology team.
Severe breathing difficulty
Call 999 or attend emergency care if you develop severe difficulty breathing, become faint or confused, or have sudden severe chest symptoms.
Emergency symptoms should not wait for a private outpatient appointment.
If you are receiving chemotherapy: fever, shivering or other signs of infection may require urgent assessment even if respiratory symptoms seem relatively mild. Follow the specific emergency instructions provided by your cancer treatment team.
Types of lung complications from cancer therapy
Cancer therapy can affect the lungs through several different mechanisms. Identifying the correct mechanism is important because treatment for inflammation may be very different from treatment for infection.
Radiation pneumonitis and radiation-induced lung injury
Radiotherapy involving the chest can cause inflammation in normal lung tissue exposed to radiation. This is called radiation pneumonitis and commonly presents with breathlessness and a dry cough, sometimes with fever.
It often develops in the weeks or months following radiotherapy. The location and appearance of changes on CT, together with the radiotherapy field and timing of symptoms, can help with diagnosis.
Radiation fibrosis
Some people develop longer-term scarring and stiffness in lung tissue after radiotherapy. This is known as radiation fibrosis. The extent varies and may be visible on follow-up imaging even when symptoms are limited.
More extensive fibrosis may contribute to persistent breathlessness or reduced exercise tolerance.
Immune checkpoint inhibitor pneumonitis
Immune checkpoint inhibitors stimulate immune activity against cancer. In some patients the immune response also causes inflammation in healthy organs, including the lungs. This is known as immune checkpoint inhibitor pneumonitis or immunotherapy-related pneumonitis.
It may cause cough, breathlessness, fever or chest discomfort, but imaging appearances vary considerably. Infection and cancer progression may need to be actively considered before the diagnosis is established.
Drug-induced pneumonitis and interstitial lung disease
Some chemotherapy drugs, targeted cancer treatments and other systemic anti-cancer therapies can cause inflammatory injury to the lung. Terms such as drug-induced pneumonitis and drug-induced interstitial lung disease may be used.
The likelihood, timing and pattern depend on the individual treatment. Reviewing exactly which medicines have been given, when symptoms started and how CT appearances have evolved is therefore important.
Respiratory infection and opportunistic infection
Chemotherapy, corticosteroids and some other cancer treatments can reduce immune defences. This can increase susceptibility to ordinary respiratory infections and, in some circumstances, infections caused by organisms that are less likely to cause disease in people with a normal immune system.
Microbiology testing and sometimes bronchoscopy may be useful when infection is suspected or the cause of an abnormal CT remains uncertain.
Other causes of respiratory symptoms during cancer treatment
Not every episode of breathlessness during cancer treatment is caused by direct lung toxicity. Other possibilities include pulmonary embolism, anaemia, fluid around the lungs, cardiac complications, asthma or COPD, infection, cancer progression and deconditioning.
Considering these alternative or overlapping diagnoses is an important part of respiratory assessment.
Risk factors for lung complications of cancer treatment
Risk is influenced by the cancer treatment being used, previous therapies and the patient's underlying lung health. Having a risk factor does not mean that a lung complication will necessarily occur.
Pre-existing lung disease
Asthma, COPD, bronchiectasis, interstitial lung disease or previous significant lung injury may affect respiratory reserve and interpretation of new symptoms.
Previous chest radiotherapy
Previous radiation exposure can be relevant when assessing new inflammatory changes and the cumulative impact of treatment on lung tissue.
Combination cancer therapy
The interaction between radiotherapy, systemic treatments and immunotherapy may influence pulmonary risk in some treatment settings.
Smoking history
Smoking can reduce respiratory reserve and may coexist with COPD or other underlying lung disease.
Immunosuppression
Reduced immune function from cancer or its treatment can increase vulnerability to respiratory infections, including opportunistic infections in selected patients.
Previous treatment reactions
Previous pulmonary toxicity and the timing of earlier treatments may be relevant when assessing a new respiratory problem.
How Dr Ricardo José investigates lung complications of cancer treatment
Depending on your symptoms, examination, clinical history and cancer treatment, investigations may include a combination of imaging, lung function testing, blood tests and microbiology. The aim is not simply to identify an abnormality, but to understand what is causing it and how significantly it is affecting the lungs.
Detailed history and examination
This includes the nature and timing of respiratory symptoms, oxygen levels where appropriate, previous lung disease, smoking history, infection risk and a detailed review of current and previous cancer treatments.
Review of previous imaging and treatment records
Comparing current CT or chest X-ray findings with earlier scans can show when abnormalities developed and whether their distribution is compatible with previous radiotherapy or another recognised pattern of lung injury.
Chest imaging
A chest X-ray may be useful in some situations, but CT usually provides substantially more detail when pneumonitis, infection or interstitial lung disease is being considered.
Lung function tests
Spirometry and other pulmonary function measurements can help assess airflow, lung volumes and gas transfer, providing an objective measure of how lung function has been affected.
Blood tests and microbiology
Blood tests may help assess inflammation, infection, anaemia and other potential contributors to breathlessness. Sputum or other microbiological samples may be appropriate when respiratory infection is suspected.
Bronchoscopy when clinically appropriate
Bronchoscopy and bronchoalveolar lavage are not required for everyone. In selected cases they can help obtain samples from the lungs, particularly when infection or an alternative diagnosis needs to be investigated.
Additional investigations for overlapping causes
Depending on the presentation, cardiac tests, assessment for pulmonary embolism or other specialist investigations may be needed because respiratory symptoms during cancer treatment are not always caused by direct lung toxicity.
How Dr Ricardo José treats lung complications of cancer treatment
Treatment depends on the diagnosis, severity of symptoms, oxygen levels, the extent of lung involvement and the cancer treatment you are receiving. Management is therefore individualised and should be coordinated with the oncology team.
Inflammatory pneumonitis
Treatment-related pneumonitis may require close monitoring, changes to cancer therapy and anti-inflammatory treatment such as corticosteroids, depending on severity and the underlying cause. Infection needs appropriate consideration before immunosuppression is escalated.
Respiratory infection
When infection is suspected, treatment is guided by clinical severity, immune status and microbiology where available. Patients who are significantly immunocompromised or unwell may require urgent hospital-based assessment and treatment.
Underlying lung disease
Asthma, COPD, bronchiectasis or another pre-existing respiratory condition may also need treatment optimisation if it is contributing to cough or breathlessness.
Persistent lung impairment
Where there has been lasting respiratory impairment, management may include symptom control, rehabilitation, exercise advice, airway clearance where relevant, monitoring of lung function and assessment for oxygen when clinically indicated.
Alternative diagnoses
If symptoms arise from a different problem such as pulmonary embolism, cardiac disease, anaemia or pleural disease, treatment should be directed towards that cause with the appropriate specialist team.
Communication with your cancer treatment team
Respiratory complications can affect decisions about the timing and safety of cancer treatment, so communication between respiratory and oncology specialists is important.
Dr Ricardo José communicates with treating oncologists to share respiratory findings, discuss the likely diagnosis and coordinate management where appropriate. He works closely with oncology specialists, including colleagues at The London Clinic and The Royal Marsden.
Clarifying the respiratory diagnosis
Helping distinguish treatment-related inflammation from infection, underlying respiratory disease and other causes of abnormal imaging.
Assessing severity
Establishing the clinical and physiological impact of the lung problem to help inform wider treatment decisions.
Coordinating follow-up
Monitoring symptoms, lung function or imaging where this is useful and sharing relevant findings with the wider clinical team.
Why see Dr Ricardo José for lung complications of cancer treatment?
Dr Ricardo José is a Consultant Respiratory Physician with a specialist interest in respiratory complications associated with cancer treatment and immunosuppression.
He is a Consultant in Respiratory Medicine at Royal Brompton Hospital and provides private respiratory consultations in London.In his NHS role he also offers respiratory advise to oncology and haemato-oncology patients from the Royal Marsden Hospital. His assessment focuses on establishing the cause of symptoms or abnormal imaging and developing a personalised investigation and management plan.
Assessment of complex respiratory symptoms
Detailed evaluation of breathlessness, cough, infection concerns and abnormal scans arising during or after cancer treatment.
Consideration of competing diagnoses
Infection, treatment toxicity and underlying respiratory disease can overlap. Assessment considers alternative explanations rather than assuming every scan abnormality represents pneumonitis.
Appropriate respiratory investigations
Access to investigations such as detailed chest imaging, lung function testing and microbiology, with bronchoscopy or other specialist testing when clinically indicated.
Coordination with oncology
Respiratory findings can be communicated with the treating oncology team to support coordinated decision-making where cancer treatment and lung management intersect.
Private consultations in London
Specialist respiratory assessment is available privately for patients who require investigation, review of an existing diagnosis or a respiratory opinion alongside their cancer care.
What patients say about Dr Ricardo José
Rather than reproducing or selectively quoting individual reviews here, you can read patient feedback about consultations with Dr Ricardo José on the dedicated patient feedback page and independently on Doctify.
Questions about cancer treatment and lung complications
These answers provide general information. Your own risk, investigations and treatment depend on the cancer therapy you are receiving and your individual clinical circumstances.
Can cancer treatment cause lung problems?
Yes. Several forms of cancer treatment can affect the lungs, although most patients will not develop a serious pulmonary complication. Possible problems include radiation pneumonitis, immunotherapy-related pneumonitis, drug-induced interstitial lung disease, infection and longer-term radiation fibrosis.
What is pneumonitis?
Pneumonitis means inflammation of lung tissue. In people receiving cancer treatment it may be associated with radiotherapy, immunotherapy or other cancer medicines. It can cause breathlessness and cough and may produce characteristic abnormalities on CT, although these appearances are not always specific.
Is pneumonitis the same as pneumonia?
No. Pneumonia generally refers to an infection of the lung, whereas pneumonitis usually describes non-infectious inflammation. However, the symptoms and scan appearances can overlap, and infection may need to be excluded before treatment-related pneumonitis can be managed confidently.
How soon after radiotherapy can radiation pneumonitis occur?
Radiation pneumonitis commonly develops in the weeks to months following radiotherapy involving lung tissue. The exact timing varies according to the treatment and individual patient. Later changes may include scarring or fibrosis within the irradiated region.
Can immunotherapy cause breathlessness or cough?
Yes. Immune checkpoint inhibitors can sometimes cause inflammation of the lungs. A new persistent cough, breathlessness, wheeze or deterioration in an existing breathing problem should be reported promptly to your cancer treatment team because pneumonitis can range from mild to serious.
How is immunotherapy-related pneumonitis diagnosed?
Diagnosis usually combines your symptoms, the timing and type of immunotherapy, oxygen measurements, chest imaging and consideration of alternative diagnoses. Blood tests, microbiology, lung function testing or bronchoscopy may be useful in selected cases. No single CT appearance confirms every case.
Will I have to stop my cancer treatment if pneumonitis is suspected?
Not necessarily. Decisions about pausing, changing or restarting cancer treatment depend on the suspected cause and severity of the lung complication as well as the cancer treatment itself. These decisions should be coordinated between your oncology and respiratory teams.
Can Dr Ricardo José provide a second opinion on an abnormal CT scan?
Yes. A respiratory consultation can review symptoms, cancer treatment history, previous and current imaging and any existing test results. Dr Ricardo José can then advise whether further respiratory investigation may help distinguish treatment toxicity from infection or another cause.
Concerned about respiratory symptoms during or after cancer treatment?
Book a private consultation with Dr Ricardo José in London for specialist respiratory assessment of breathlessness, cough, recurrent infection or abnormal lung imaging associated with cancer treatment.
